Welcome to LookChem.com Sign In|Join Free

CAS

  • or

518-28-5

Post Buying Request

518-28-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Podophyllotoxin Powder Extract, Podophyllotoxin 98%,CAS No: 518-28-5

    Cas No: 518-28-5

  • USD $ 400.0-500.0 / Kilogram

  • 1 Kilogram

  • 1 Metric Ton/Day

  • Kono Chem Co.,Ltd
  • Contact Supplier

518-28-5 Usage

Description

Podophyllotoxin (2,3-butyl-4-aromatic naphthene) is isolated from guijiu(Podophyllum) . There are two species as the main source of podophyllotoxin, Podophyllum hexandrum Royle and Podophyllum peltatum .Although podophyllotoxin has significant antitumor and antiviral activities, it showed several toxicity and side effects. Podophyllotoxin derivatives, etoposide (VP-16-213), Etopophos, amino sugar etoposide (NK6l1), and teniposide (VM26), have been developed as anticancer drugs. They are used to treat small cell lung cancer, testicular cancer, acute leukemia, malignant lymphoma, etc. But podophyllotoxin derivatives are not free of toxicity. Besides the narrowing of the anticancer spectrum and low water solubility, these drugs could induce severe myelosuppression, gastrointestinal side effects, etc.Although the synthetic and biosynthetic pathways of podophyllotoxin have been elucidated, it is still the most effective, economic, and fast way to extract podophyllotoxin from the plant.

Physical properties

Appearance: white needle crystal powder. Solubility: freely soluble in chloroform, acetone, ethyl acetate, and benzene; soluble in ethanol and ethyl ether; and insoluble in water. Melting point: after drying the melting point is 183–184°C. Specific optical rotation: 132.7°C (chloroform).

History

Podophyllotoxin was first found in the Podophyllum peltatum L.?The first time to isolate podophyllotoxin from podophyllin was in 1880. In 1942, it was found that venereal warts could be effectively treated by application of podophyllin.Subsequently, podophyllotoxin was reported to inhibit the growth of the tumor through the inhibition of the microtubule formation. The chemical structure of podophyllotoxin was elucidated in 1951.In the 1960s, two main podophyllotoxin derivatives were synthesized, etoposide and teniposide (VM-26) . In 1983, etoposide was approved by FDA.?Etoposide and teniposide are used in frontline cancer therapy against various cancer types, such as small cell lung cancer, testicular cancer, etc. In 1996, etoposide phosphate analog (Etopophos) was launched in America. Etopophos is the prodrug of etoposide and can be rapidly absorbed and completely converted to the parent compound in?vivo. In 1990, WHO recommended 0.5% podophyllotoxin as the first-line drug for the treatment of condyloma acuminatum. Podophyllotoxin creams and gels are nowadays widely used in clinical practice.

Uses

Different sources of media describe the Uses of 518-28-5 differently. You can refer to the following data:
1. Skin treatment for genital warts caused by some types of HPVs.
2. antineoplastic, inhibits microtubule assembly, and human DNA topoisomerase II; antimitotic agent
3. Podophyllotoxin is a non-alkaloid toxin lignan extracted from the roots and rhizomes of Podophyllum species. It binds to topoisomerase II during the late S and early G2 stage, blocking tubulin polymerization and, thus, inhibiting mitosis. In addition to being used as a cathartic, purgative, antiviral agent, vesicant, and antihelminthic, podophyllotoxin is the starting material for the semi-synthesis of the anti-cancer drugs etoposide , teniposide , and etopophos.

Definition

ChEBI: An organic heterotetracyclic compound that has a furonaphthodioxole skeleton bearing a 3,4,5-trimethoxyphenyl substituent. It is found in the roots and rhizomes of Podophyllum species and is used for the topical treatment of genital warts.

Indications

Podophyllotoxin (Podofilox) is available alone and as the main cytotoxic ingredient in podophyllin (25% podophyllum resin), a mixture of toxic chemicals derived from May apple plants. The active ingredients inhibit cell mitosis. The drugs are used to treat condylomata acuminata. The most common toxic effects are skin irritation and less commonly, ulceration. Systemic absorption of podophyllin can occur (especially if applied to large, inflamed areas or mucosal surfaces), with gastrointestinal, hematological, renal, and hepatotoxic effects. In addition, seizures and peripheral neuropathy have been reported.

Brand name

Condylox (Oclassen).

Biochem/physiol Actions

Inhibits microtubule assembly; antineoplastic.

Pharmacology

Antineoplastic and antiviral activities are the most pronounced pharmacological. effects of podophyllotoxin . Podophyllotoxin shows a significant inhibitory effect on the division and proliferation of epithelial cells infected by human papillomavirus (HPV), disrupts the cell cytoskeleton, and induces the necrosis and shedding of warts. It was shown that the antitumor effect of podophyllotoxin is associated with the inhibition of microtubule assembly and the induction of apoptosis. However, the antitumor effect of podophyllotoxin analogs, such as etoposide, teniposide, and Etopophos, is related to disparate mechanisms including the inhibition of DNA topoisomerase II activity and the formation of stable nucleic acid-drugenzyme complex, which induce DNA double-strand or single-strand break and eventually lead to cell death . It was also found that podophyllotoxin derivatives have immunosuppressive and anti-inflammatory effects.

Clinical Use

Podophyllotoxin is a useful agent for the treatment of condyloma acuminatum . Podophyllotoxin and its derivatives are also widely used in the treatment of cancer, such as lymphomas and lung carcinoma. Because of the several toxicity of podophyllotoxin, for example, the irritation of skin and mucous membranes, combination therapies are used to treat condyloma acuminatum or cancer.

Anticancer Research

Different sources of media describe the Anticancer Research of 518-28-5 differently. You can refer to the following data:
1. Podophyllotoxin (PTOX) is an aryl-tetralin lignan and has been originallyisolated from Podophyllum peltatum L. (American podophyllum or Mayapple;family Podophyllaceae). Later, it is also isolated from several species like P.hexandrum Royle (Indian podophyllum) and P. pleianthum (Taiwanese podophyllum).PTOX has also been reported in other plants such as Linum spp., Callitrisspp., Juniperus spp., Thuja spp., Hyptis spp., Thymus spp., Teucrium spp., Nepetaspp., Dysosma spp., Diphylleia spp., and Jeffersoniana spp. (Ionkova 2007;Yousefzadi et al. 2010). PTOX shows strong cytotoxic activity against various cancercell lines. However, PTOX is too toxic for the treatment of neoplastic diseasesin humans; it is used as a precursor for chemical synthesis of semisynthetic antineoplasticdrugs, etoposide, Etopophos, and teniposide , which are successfullyused as antitumor agents (Holthuis 1988; Cragg and Newman 2005).Podophyllotoxin derivatives are used in the treatment of lymphomas, acute leukemia,and testicular, lung, ovarian, bladder, and brain cancer (Srivastava et al. 2005).Podophyllum spp. are the major source of PTOX, and their availability is limited innature, and some species are categorized as endangered. Moreover, the chemicalsynthesis of podophyllotoxin is an expensive process; therefore, biotechnologicalproduction of podophyllotoxin using plant cell and tissue cultures has been preferredby various research groups (Farkya et al. 2004).
2. Podophyllotoxin istoxic for humancells and is aprecursor ofsemisyntheticantineoplastic drugs(e.g., etoposide,etopophos, andteniposide).

Purification Methods

The toxin recrystallises form *C6H6 (with 0.5C6H6), EtOH/*C6H6, aqueous EtOH (with 1-1.5H2O, m 114-115o) and CH2Cl2/pentane. When dried at 100o/10mm it has m 183-184o. [UV: Stoll et al. Helv Chim Acta 37 1747 1954, IR: Schecler et al. J Org Chem 21 288 1956.] It is an inhibitor of microtubule assembly [Prasad et al. Biochemistry 25 739 1986]. [Beilstein 19/10 V 666.]

Check Digit Verification of cas no

The CAS Registry Mumber 518-28-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,1 and 8 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 518-28:
(5*5)+(4*1)+(3*8)+(2*2)+(1*8)=65
65 % 10 = 5
So 518-28-5 is a valid CAS Registry Number.
InChI:InChI=1/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19+,20-/m0/s1

518-28-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (P4405)  Podophyllotoxin  

  • 518-28-5

  • P4405-50MG

  • 451.62CNY

  • Detail
  • Sigma

  • (P4405)  Podophyllotoxin  

  • 518-28-5

  • P4405-100MG

  • 792.09CNY

  • Detail

518-28-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name podophyllotoxin

1.2 Other means of identification

Product number -
Other names Furo[3‘,4‘:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, [5R-(5-,5aα,8a-,9-)]-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:518-28-5 SDS

518-28-5Synthetic route

Conditions
ConditionsYield
With L-Selectride In tetrahydrofuran at -78℃; for 0.25h;93%
With L-Selectride In tetrahydrofuran at -78℃; for 1.5h; Inert atmosphere;87%
With lithium tri-t-butoxyaluminum hydride In diethyl ether at -78 - 20℃; for 18h; optical yield given as %de; diastereoselective reaction;79%
With L-Selectride In tetrahydrofuran at -78℃; for 2h; Inert atmosphere;70%
(5R,6R,7R,8R)-methyl 8-hydroxy-7-(hydroxymethyl)-5-(3,4,5-trimethoxyphenyl)-5,6,7,8-tetrahydronaphtho[2,3-d][1,3]dioxole-6-carboxylate
1256-91-3

(5R,6R,7R,8R)-methyl 8-hydroxy-7-(hydroxymethyl)-5-(3,4,5-trimethoxyphenyl)-5,6,7,8-tetrahydronaphtho[2,3-d][1,3]dioxole-6-carboxylate

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
With 4 A molecular sieve; zinc(II) chloride In tetrahydrofuran at 64℃; for 2.5h;85%
With molecular sieve; zinc(II) chloride In tetrahydrofuran75%
With 4 A molecular sieve; zinc(II) chloride In tetrahydrofuran for 2.5h; Heating; Yield given;
(1R,2R,3R,4R)-4-O-(2'-trimethylsilylethoxy)methylpodophyllotoxin
261158-30-9

(1R,2R,3R,4R)-4-O-(2'-trimethylsilylethoxy)methylpodophyllotoxin

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
With ethanethiol; magnesium bromide In diethyl ether; benzene at 0 - 20℃; for 11h; SEM deprotection;81%
(5R,5aR,8aR,9R)-9-((tert-butyldimethylsilyl)oxy)-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one
112711-16-7

(5R,5aR,8aR,9R)-9-((tert-butyldimethylsilyl)oxy)-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
With triethylamine hydrofluoride In acetonitrile for 72h; Ambient temperature;79%
With tetrabutyl ammonium fluoride; acetic acid In tetrahydrofuran at 0℃; for 2h; Inert atmosphere;54%
3-methyl-butan-2-one
563-80-4

3-methyl-butan-2-one

A

7α-[(2R)-2-hydroxy-3-methylbut-2-yl]epi-podophyllotoxin

7α-[(2R)-2-hydroxy-3-methylbut-2-yl]epi-podophyllotoxin

B

7α-[(2S)-2-hydroxy-3-methylbut-2-yl]epi-podophyllotoxin

7α-[(2S)-2-hydroxy-3-methylbut-2-yl]epi-podophyllotoxin

D

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere;A 45%
B 9%
C n/a
D n/a
Conditions
ConditionsYield
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere; optical yield given as %de;A 45%
B 9%
C n/a
D n/a
C32H35NO8S

C32H35NO8S

A

epipodophyllotoxin
4375-07-9

epipodophyllotoxin

B

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
With trifluoroacetic acid In tetrahydrofuran; water at 0 - 25℃; for 27h; Inert atmosphere;A 33%
B 43%
With trifluoroacetic acid In tetrahydrofuran; water at 0 - 20℃; for 24h; Overall yield = 76 %; Overall yield = 43 mg;
Conditions
ConditionsYield
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere;A 40%
B n/a
C n/a
Conditions
ConditionsYield
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere; optical yield given as %de;A 40%
B 7%
C n/a
D n/a
Conditions
ConditionsYield
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere; optical yield given as %de;A 40%
B 8%
C n/a
D n/a
Tetrahydro-4H-pyran-4-one
29943-42-8

Tetrahydro-4H-pyran-4-one

A

7α-(4-hydroxytetrahydropyran-4-yl)podophyllotoxin

7α-(4-hydroxytetrahydropyran-4-yl)podophyllotoxin

B

7β-(4-hydroxytetrahydropyran-4-yl)podophyllotoxin

7β-(4-hydroxytetrahydropyran-4-yl)podophyllotoxin

D

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere; optical yield given as %de;A 38%
B 15%
C n/a
D n/a
3-Cyclohexene-1-carboxaldehyde
100-50-5

3-Cyclohexene-1-carboxaldehyde

A

7α-[(1R)-1-cyclohex-3-enyl-1-hydroxymethyl]epi-podophyllotoxin

7α-[(1R)-1-cyclohex-3-enyl-1-hydroxymethyl]epi-podophyllotoxin

B

7α-[(1S)-1-cyclohex-3-enyl-1-hydroxymethyl]epi-podophyllotoxin

7α-[(1S)-1-cyclohex-3-enyl-1-hydroxymethyl]epi-podophyllotoxin

D

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere;A 38%
B 9%
C n/a
D n/a
Conditions
ConditionsYield
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere; optical yield given as %de;A 35%
B 5%
C n/a
D n/a
bicyclo[3.3.1]nonan-9-one
17931-55-4

bicyclo[3.3.1]nonan-9-one

A

7α-(9-hydroxybicyclo[3.3.1]non-9-yl)podophyllotoxin

7α-(9-hydroxybicyclo[3.3.1]non-9-yl)podophyllotoxin

B

7β-(9-hydroxybicyclo[3.3.1]non-9-yl)podophyllotoxin

7β-(9-hydroxybicyclo[3.3.1]non-9-yl)podophyllotoxin

D

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere; optical yield given as %de;A 30%
B 20%
C n/a
D n/a
acetaldehyde
75-07-0

acetaldehyde

2,2-dimethoxy-propane
77-76-9

2,2-dimethoxy-propane

A

7α-([(1S)-1-hydroxyethyl]-2,2,5-trimethyl-1,3-dioxolan-4-yl)epi-podophyllotoxin acetonide

7α-([(1S)-1-hydroxyethyl]-2,2,5-trimethyl-1,3-dioxolan-4-yl)epi-podophyllotoxin acetonide

B

7α-([(1R)-1-hydroxyethyl]-2,2,5-trimethyl-1,3-dioxolan-4-yl)epi-podophyllotoxin acetonide

7α-([(1R)-1-hydroxyethyl]-2,2,5-trimethyl-1,3-dioxolan-4-yl)epi-podophyllotoxin acetonide

D

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
Stage #1: acetaldehyde; podophyllotoxone With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere;
Stage #2: 2,2-dimethoxy-propane With chloro-trimethyl-silane In acetone for 0.0833333h; Inert atmosphere;
A 15%
B 30%
C n/a
D n/a
Conditions
ConditionsYield
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere;A 30%
B 8%
C n/a
D n/a
Conditions
ConditionsYield
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere;A 30%
B n/a
C n/a
Conditions
ConditionsYield
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere;A 15%
B n/a
C n/a
podophyllotoxin-7′-O-β-D-glucopyranoside
16481-54-2

podophyllotoxin-7′-O-β-D-glucopyranoside

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
With emulsin-substance
4-demethylpodophyllotoxin
40505-27-9

4-demethylpodophyllotoxin

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
With methanol; diethyl ether; acetone
In methanol; diethyl ether; acetone for 24h; Ambient temperature;20 mg
podophyllotoxinyl acetate
1180-34-3

podophyllotoxinyl acetate

A

(5aR,8aS,9R)-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxole-5,8-dione
477-48-5

(5aR,8aS,9R)-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxole-5,8-dione

C

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
In dimethyl sulfoxide for 72h; Forsythia intermedia; Yield given. Yields of byproduct given;
podophyllotoxin-7′-O-β-D-glucopyranoside
16481-54-2

podophyllotoxin-7′-O-β-D-glucopyranoside

B

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
In dimethyl sulfoxide for 72h; Forsythia intermedia; Yield given. Yields of byproduct given;
Conditions
ConditionsYield
With aspergillus niger sp In ethanol for 72h;
Multi-step reaction with 3 steps
1: N-Bromosuccinimide / 1,4-dioxane / 0.33 h / 20 °C / Inert atmosphere; Schlenk technique; Irradiation
2: dipyridinium dichromate / dichloromethane / 1 h / 0 - 20 °C / Inert atmosphere
3: L-Selectride / tetrahydrofuran / 1.5 h / -78 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1: chromium(VI) oxide; 3,5-dimethyl-1H-pyrazole / dichloromethane / 2 h / 0 °C
2: L-Selectride / tetrahydrofuran / 0.25 h / -78 °C
View Scheme
Conditions
ConditionsYield
With zinc(II) tetrahydroborate In diethyl ether; benzene for 3.5h; Product distribution; Ambient temperature; different reducing agents, solvents, reaction temperatures and times;
With zinc(II) tetrahydroborate In diethyl ether; benzene for 3.5h; Ambient temperature; Yield given. Yields of byproduct given;
9-Chloro-9-desoxypodophyllotoxin
7401-22-1

9-Chloro-9-desoxypodophyllotoxin

A

4β-azido-4-deoxypodophyllotoxin
155252-34-9

4β-azido-4-deoxypodophyllotoxin

B

4'-O-trimethyl-4-azido-4-desoxypodophyllotoxin
155325-17-0

4'-O-trimethyl-4-azido-4-desoxypodophyllotoxin

C

epipodophyllotoxin
4375-07-9

epipodophyllotoxin

D

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
With sodium azide In water; acetone at 50℃; for 5h; Yield given. Yields of byproduct given;
(3S,4R)-4-(Benzenesulfinyl-benzo[1,3]dioxol-5-yl-methyl)-3-[hydroxy-(3,4,5-trimethoxy-phenyl)-methyl]-dihydro-furan-2-one

(3S,4R)-4-(Benzenesulfinyl-benzo[1,3]dioxol-5-yl-methyl)-3-[hydroxy-(3,4,5-trimethoxy-phenyl)-methyl]-dihydro-furan-2-one

podofilox
518-28-5

podofilox

Conditions
ConditionsYield
With boron trifluoride diethyl etherate; mercury(II) oxide for 28h; Yield given;
hydrogenchloride
7647-01-0

hydrogenchloride

acetone
67-64-1

acetone

epipodophyllotoxin
4375-07-9

epipodophyllotoxin

podofilox
518-28-5

podofilox

hydrogenchloride
7647-01-0

hydrogenchloride

podophyllinic acid hydrazide
78178-41-3

podophyllinic acid hydrazide

podofilox
518-28-5

podofilox

pyrrolidine
123-75-1

pyrrolidine

podofilox
518-28-5

podofilox

picropodophyllic acid pyrrolidinyl amide
291272-81-6

picropodophyllic acid pyrrolidinyl amide

Conditions
ConditionsYield
In benzene at 50℃; for 46h; Inert atmosphere;100%
ethylamine
75-04-7

ethylamine

podofilox
518-28-5

podofilox

N-ethyl picropodophyllamide
116606-76-9

N-ethyl picropodophyllamide

Conditions
ConditionsYield
In water for 1.5h; Reflux;100%
podofilox
518-28-5

podofilox

2’-chloropodophyllotoxin
1449601-57-3

2’-chloropodophyllotoxin

Conditions
ConditionsYield
With N-chloro-succinimide; 2,2,6,6-tetramethylpiperidin-1-oxoammonium trifluoromethanesulfonate In chloroform at 25℃; for 12h; Reagent/catalyst; Schlenk technique;99%
With N-chloro-succinimide In N,N-dimethyl-formamide at 0 - 20℃; for 20h;85%
With N-chloro-succinimide at 0 - 20℃; for 24h;85%
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

podofilox
518-28-5

podofilox

(5R,5aR,8aR,9R)-9-((tert-butyldimethylsilyl)oxy)-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one
112711-16-7

(5R,5aR,8aR,9R)-9-((tert-butyldimethylsilyl)oxy)-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide98%
With 1H-imidazole90%
With 1H-imidazole In N,N-dimethyl-formamide90%
9,12-epoxy-9,11-octadecadienoic acid
4179-44-6

9,12-epoxy-9,11-octadecadienoic acid

podofilox
518-28-5

podofilox

4-O-podophyllotoxinyl 9,12-epoxyoctadeca-9,11-dienoate

4-O-podophyllotoxinyl 9,12-epoxyoctadeca-9,11-dienoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 2h; Esterification;98%
trans-ximenynic acid
2578-97-4, 136145-04-5, 557-58-4

trans-ximenynic acid

podofilox
518-28-5

podofilox

4-O-podophyllotoxinyl octadec-11E-en-9-ynoate

4-O-podophyllotoxinyl octadec-11E-en-9-ynoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 2h; Esterification;98%
5,6-dithia-decanedioic acid
2906-60-7

5,6-dithia-decanedioic acid

podofilox
518-28-5

podofilox

C52H54O18S2

C52H54O18S2

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 2h; Inert atmosphere;98%
C39H32O9
1374991-25-9

C39H32O9

podofilox
518-28-5

podofilox

C49H44O15

C49H44O15

Conditions
ConditionsYield
With H3P*C18H15P*C2F6NO4S2(1-)*Au(1+) In dichloromethane at 20℃; Inert atmosphere; Green chemistry;98%
t-butyldimethylsiyl triflate
69739-34-0

t-butyldimethylsiyl triflate

podofilox
518-28-5

podofilox

(5R,5aR,8aR,9R)-9-((tert-butyldimethylsilyl)oxy)-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one
112711-16-7

(5R,5aR,8aR,9R)-9-((tert-butyldimethylsilyl)oxy)-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one

Conditions
ConditionsYield
With 2,6-dimethylpyridine In dichloromethane at 0℃; silylation;97%
succinic acid
110-15-6

succinic acid

podofilox
518-28-5

podofilox

C48H46O18

C48H46O18

Conditions
ConditionsYield
With dmap; 1,2-dichloro-ethane In dichloromethane at 20℃; for 24h; Inert atmosphere;97%
ortho-(cyclopropylethynyl)benzoic acid
1313028-09-9

ortho-(cyclopropylethynyl)benzoic acid

podofilox
518-28-5

podofilox

podophyllotoxin 4-O-ortho-cyclopropylethynylbenzoate

podophyllotoxin 4-O-ortho-cyclopropylethynylbenzoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; for 2h;97%
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20 - 35℃; for 2h; Inert atmosphere;97%
8-(2-adamantyloxy)-8-oxo-octanoic acid
1338797-64-0

8-(2-adamantyloxy)-8-oxo-octanoic acid

podofilox
518-28-5

podofilox

2-adamantyl (5R,5aR,8aR,9R)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,-3]benzodioxol-5-yl suberate

2-adamantyl (5R,5aR,8aR,9R)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,-3]benzodioxol-5-yl suberate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 12h;97%
podofilox
518-28-5

podofilox

Conditions
ConditionsYield
With phosphorus tribromide In benzene for 1h; Heating;96%
With hydrogen bromide In diethyl ether; dichloromethane at 0℃; for 48h;
cis-9,trans-11-octadecadienoic acid
544-70-7, 544-71-8, 872-23-1, 1839-11-8, 2540-56-9

cis-9,trans-11-octadecadienoic acid

podofilox
518-28-5

podofilox

4-O-podophyllotoxinyl octadeca-9Z,11E-dienoate

4-O-podophyllotoxinyl octadeca-9Z,11E-dienoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 2h; Esterification;96%
11,12-E-epoxyoctadec-9-ynoic acid

11,12-E-epoxyoctadec-9-ynoic acid

podofilox
518-28-5

podofilox

4-O-podophyllotoxinyl 11,12-E-epoxyoctadec-9-ynoate

4-O-podophyllotoxinyl 11,12-E-epoxyoctadec-9-ynoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 2h; Esterification;96%
8-(2-adamantyloxy)-8-oxo-octanoic acid
1338797-64-0

8-(2-adamantyloxy)-8-oxo-octanoic acid

podofilox
518-28-5

podofilox

2-adamantyl (5R,5aR,8aR,9R)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,-3]benzodioxol-5-yl suberate

2-adamantyl (5R,5aR,8aR,9R)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,-3]benzodioxol-5-yl suberate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 12h;97%
podofilox
518-28-5

podofilox

1α-bromo-desoxypodophyllotoxin
106636-74-2

1α-bromo-desoxypodophyllotoxin

Conditions
ConditionsYield
With phosphorus tribromide In benzene for 1h; Heating;96%
With hydrogen bromide In diethyl ether; dichloromethane at 0℃; for 48h;
podofilox
518-28-5

podofilox

4'-O-trimethyl-4-azido-4-desoxypodophyllotoxin
155325-17-0

4'-O-trimethyl-4-azido-4-desoxypodophyllotoxin

Conditions
ConditionsYield
With sodium azide; trifluoroacetic acid In dichloromethane at 25℃; Cooling with ice;96%
With sodium azide; phosphorus tribromide
Multi-step reaction with 2 steps
1: PBr3 / benzene / 1 h / Heating
2: NaN3 / dimethylformamide
View Scheme
Boc-D-Trp-OH
5241-64-5

Boc-D-Trp-OH

podofilox
518-28-5

podofilox

(5R,9R)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl (tert-butoxycarbonyl)-D-tryptophanate

(5R,9R)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl (tert-butoxycarbonyl)-D-tryptophanate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 4h;95.5%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; Inert atmosphere;72%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

podofilox
518-28-5

podofilox

(5R,8aR,9R)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5,5a,6,8,8a,9-hexahydrofuro[30,4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl(tert-butoxycarbonyl)alaninate

(5R,8aR,9R)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5,5a,6,8,8a,9-hexahydrofuro[30,4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl(tert-butoxycarbonyl)alaninate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 12h;95.4%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 12h;95.4%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 4h;92.1%
podofilox
518-28-5

podofilox

epipodophyllotoxin
4375-07-9

epipodophyllotoxin

Conditions
ConditionsYield
Stage #1: podofilox With methanesulfonic acid; sodium bromide In acetonitrile at 20℃; for 1h; Inert atmosphere; Green chemistry;
Stage #2: With barium carbonate In water at 20℃; Green chemistry;
95%
Stage #1: podofilox With sodium iodide In acetonitrile for 0.0833333h;
Stage #2: With boron trifluoride diethyl etherate In acetonitrile at 0 - 20℃;
Stage #3: With water; barium carbonate In acetone; acetonitrile at 20℃; for 0.5h;
85%
Stage #1: podofilox With sodium iodide In acetonitrile at 20℃; for 0.0833333h;
Stage #2: With boron trifluoride diethyl etherate at 0℃; for 0.25h;
Stage #3: With barium carbonate In water; acetone at 20℃; for 2h;
72%
Phenoxyacetyl chloride
701-99-5

Phenoxyacetyl chloride

podofilox
518-28-5

podofilox

podophyllotoxinyl phenoxyacetate

podophyllotoxinyl phenoxyacetate

Conditions
ConditionsYield
In pyridine; benzene Ambient temperature;95%
allyl-trimethyl-silane
762-72-1

allyl-trimethyl-silane

podofilox
518-28-5

podofilox

4-deoxy-4-allyl-(epi)-podophyllotoxin
136723-80-3

4-deoxy-4-allyl-(epi)-podophyllotoxin

Conditions
ConditionsYield
With 4 A molecular sieve; boron trifluoride diethyl etherate In dichloromethane at 25℃; for 4h;95%
N-(tert-butoxycarbonyl)sarcosine
13734-36-6

N-(tert-butoxycarbonyl)sarcosine

podofilox
518-28-5

podofilox

(5R,8aR,9R)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5,5a,6,8,8a,9-hexahydrofuro[30,4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl-N-(tertbutoxycarbonyl)-N-methylglycinate

(5R,8aR,9R)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5,5a,6,8,8a,9-hexahydrofuro[30,4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl-N-(tertbutoxycarbonyl)-N-methylglycinate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 4h;94.2%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 12h;90.3%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 12h;90.3%
succinic acid anhydride
108-30-5

succinic acid anhydride

podofilox
518-28-5

podofilox

Succinylpodophyllotoxin
47789-93-5

Succinylpodophyllotoxin

Conditions
ConditionsYield
With dmap; triethylamine In chloroform at 20℃; for 1h; Inert atmosphere;94%
With 1H-imidazole; dmap at 20℃; for 13h;91%
With pyridine at 25℃; for 16h;73%
9,10-dibromooctadecanoic acid
19117-94-3

9,10-dibromooctadecanoic acid

podofilox
518-28-5

podofilox

4-O-podophyllotoxinyl 9,10-dibromooctadecanoate

4-O-podophyllotoxinyl 9,10-dibromooctadecanoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 2h; Esterification;94%
1-(tert-butoxycarbonyl)-L-proline
15761-39-4

1-(tert-butoxycarbonyl)-L-proline

podofilox
518-28-5

podofilox

1-(tert-butyl)-2-((5R,8aR,9R)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5,5a,6,8,8a,9-hexahydrofuro[30,4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl)pyrrolidine-1,2-dicarboxylate

1-(tert-butyl)-2-((5R,8aR,9R)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5,5a,6,8,8a,9-hexahydrofuro[30,4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl)pyrrolidine-1,2-dicarboxylate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 12h;94%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 12h;94%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 20h;
7-(2-adamantyloxy)-7-oxo-heptanoic acid
1338797-61-7

7-(2-adamantyloxy)-7-oxo-heptanoic acid

podofilox
518-28-5

podofilox

2-adamantyl (5R,5aR,8aR,9R)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,-3]benzodioxol-5-yl pimelate

2-adamantyl (5R,5aR,8aR,9R)-8-oxo-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,-3]benzodioxol-5-yl pimelate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 12h;94%
p-tolyl 2-O-acetyl-3,4,6-tri-O-benzyl-1-thio-β-D-galactopyranoside
897364-02-2

p-tolyl 2-O-acetyl-3,4,6-tri-O-benzyl-1-thio-β-D-galactopyranoside

podofilox
518-28-5

podofilox

7-O-(2-O-acetyl-3,4,6-tri-O-benzyl-β-D-galactopyranosyl)podophyllotoxin

7-O-(2-O-acetyl-3,4,6-tri-O-benzyl-β-D-galactopyranosyl)podophyllotoxin

Conditions
ConditionsYield
With rhodium (II) octanoate dimer; 2,6-di-tert-butyl-4-methylpyridinium trifluoromethanesulfonate; methyl 2-(4-chlorophenyl)-2-diazoacetate In dichloromethane at 0℃; for 2h; Molecular sieve;94%
hydrazine carboxamide
4426-72-6, 51433-48-8

hydrazine carboxamide

podofilox
518-28-5

podofilox

C23H27N3O9

C23H27N3O9

Conditions
ConditionsYield
With acetic acid In methanol for 6h; Reflux;94%
podofilox
518-28-5

podofilox

podophyllinic acid hydrazide
78178-41-3

podophyllinic acid hydrazide

Conditions
ConditionsYield
With acetic acid; hydrazine In methanol for 6h; Reflux;94%

518-28-5Relevant articles and documents

Asymmetric total synthesis of (-)podophyllotoxin

Hadimani, Shreeshailkumar B.,Tanpure, Rajendra P.,Bhat, Sujata V.

, p. 4791 - 4794 (1996)

Asymmetric synthesis of podophyllotoxin is achieved through tandem conjugate addition of S (-) benzyl phenyl sulfoxide to but-2-en-4-olide.

Total synthesis of podophyllotoxin and select analog designs via C–H activation

Ting, Chi P.,Tschanen, Esther,Jang, Esther,Maimone, Thomas J.

, p. 3299 - 3308 (2019/05/15)

An account of our previously disclosed total synthesis of the aryltetralin lignan natural product podophyllotoxin, a building block used in the synthesis of the FDA-approved anticancer drug etoposide, is disclosed. A C–H activation disconnection was viewed as being amenable to the preparation of E-ring modified analogs but proved challenging to execute. Various insights into palladium-catalyzed C–H arylation reactions on complex scaffolds are reported ultimately leading to the implementation of this strategy and the synthesis of compounds inaccessible by semisynthetic means.

Divergent Asymmetric Syntheses of Podophyllotoxin and Related Family Members via Stereoselective Reductive Ni-Catalysis

Xiao, Jian,Cong, Xiao-Wei,Yang, Gui-Zhen,Wang, Ya-Wen,Peng, Yu

, p. 1651 - 1654 (2018/03/23)

A nickel-catalyzed reductive cascade approach to the efficient construction of diastereodivergent cores embedded in podophyllum lignans is developed for the first time. Their gram-scale access paved the way for unified syntheses of naturally occurring podophyllotoxin and other members.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 518-28-5